Pharmafile Logo
Pharmafocus logo
Advanced Search
jon_rees

OBN chief executive Jon Rees steps down

June 24, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing OBN, jon rees, ross sommerville

UK life sciences membership organisation OBN has confirmed that its chief executive Jon Rees is stepping down in August after a decade …

Appointment
screen_shot_2015-06-23_at_08

Former Sanofi chief executive joins Waypoint

June 23, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, Viehbacher, waypoint

The former Sanofi chief executive Christopher Viehbacher is joining Geneva-headquartered business enterprise firm Waypoint Capital as a managing partner.

Appointment

Pfizer acquires meningitis vaccines from GSK

June 23, 2015
Sales and Marketing GSK, Mencevax, Nimenrix, Novartis, Pfizer, meningitis

Pharma giants GSK and Pfizer have announced an agreement to transfer the ownership of two meningitis vaccines from GlaxoSmithKline to …

News

NICE reworks cancer guidance for GPs

June 23, 2015
Sales and Marketing Cancer, GPs, NICE, UK, baker, research

The National Institute for Health and Care Excellence says thousands of lives will be saved each year if GPs and …

News
martin_birkhofer

NuCana appoints chief medical officer

June 23, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing martin birkhofer, nucana

Scottish clinical stage biopharma firm Nucana has appointed Dr Martin Birkhofer as its chief medical officer. Birkhofer, an oncologist by training, …

Appointment
Google image

Google backs Oxford Sciences Innovation

June 22, 2015
Medical Communications, Sales and Marketing Oxford, Oxford Sciences Innovation, google, ventures

Google has invested into a company that funds spinoffs from Oxford University’s technology and science departments called Oxford Sciences Innovation …

News
Eisai image

Eisai earns FDA nod for Fycompa

June 22, 2015
Sales and Marketing Eisai, FDA, Fycompa

The FDA has expanded the patient groups for whom Eisai’s epilepsy drug Fycompa is available to include people who have …

News
gci_health_carly_johns_laura_starr

GCI Health makes team changes

June 22, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GCI Health, caryl johns, claire martin, helen khan, laura starr

Healthcare comms agency GCI Health has promoted Claire Martin to associate director and Laura Starr to associate director and head …

Appointment
rare_disease_image

Overcoming barriers in rare diseases

June 22, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BIA, NHS, Shire, bates, government, nps, rare diseases

In recent months the focus on the need to develop new drugs and fund new treatments for rare diseases has …

Feature
sun pharma image

Sun Pharma sacks 18 Ranbaxy executives

June 19, 2015
Manufacturing and Production, Sales and Marketing Daiichi, India, Ranbaxy, Sun Pharma, brett wells

Sun Pharma has asked 18 executives to leave the company who were previously a part of Ranbaxy, the firm it …

News
Fake drugs image

£15.8 million UK haul of fake drugs

June 19, 2015
Manufacturing and Production, Sales and Marketing MHRA, counterfeit, drugs, fake, interpol

Counterfeit and unlicensed medicines and devices worth £15.8 million have been seized in the UK as part of a global …

News
Fitbit image

Health wearable Fitbit leads the market

June 19, 2015
Medical Communications, Sales and Marketing Apple, brett wells, digital, fitbit, health, watch, wearables

Health and fitness wearable device Fitbit has beaten expectations as the company’s shares soar following its first day of trading …

News
phil_walker

Zeus Capital names healthcare finance lead

June 19, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing phil walker, zeus capital

Investment banking boutique Zeus Capital is increasing its healthcare sector team by hiring Phil Walker to head the firm’s healthcare …

Appointment
Zydelig image

NICE wants more answers from Gilead on Zydelig

June 18, 2015
Sales and Marketing Gilead, MabThera, NICE, Roche, UK, brett wells, zydelig

The National Institute for Health and Care Excellence has not recommended Gilead’s leukaemia drug Zydelig in draft guidance.  But the …

News

EU approval for new Sanofi, Merck vaccine

June 18, 2015
Sales and Marketing EU, Europe, Merck, Sanofi, Sanofi pasteur msd, brett wells, gardasil 9

Sanofi and Merck are looking forward to a successor to their blockbuster Gardasil now that the European Commission has granted …

News
Obama image

No ‘Plan B’ for Obamacare

June 18, 2015
Medical Communications, Sales and Marketing ACT, Medicaid, Medicare, Obama, Obamacare, patient protection

US president Barack Obama has no ‘Plan B’ if a crucial Supreme Court vote in the next fortnight goes against …

News

NHS England unveils digital roadmap

June 17, 2015
Medical Communications, Sales and Marketing GP, HSCIC, NHS, NIB, brett wells, choices, digital, wearables

NHS England has laid out digital technology plans that it says will completely transform services and improve health outcomes using …

News
pam_cheng

AZ takes manufacturing head from Merck

June 17, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Pam Cheng has joined AstraZeneca from Merck to be its executive vice president of operations and IT. Cheng succeeds David …

Appointment
GSK image

GSK ploughs $95m into research institute

June 17, 2015
Research and Development, Sales and Marketing GSK, Pfizer, acquisition, altius, merger, takeover

GlaxoSmithKline is pouring $95 million into a new US research institute to investigate how a cell’s operating system works in …

News
simon_robertson

Immodulon Therapeutics makes two senior hires

June 17, 2015
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Immodulon Therapeutics

UK late-stage biopharma firm Immodulon Therapeutics has made two new senior appointments to its board of directors.  Investment fund manager …

Appointment
The Gateway to Local Adoption Series

Latest content

Japanese pharma outsources earlier as peptide development challenges grow

April 29, 2026

Study suggests phospholipid therapy may impact fatty liver disease outcomes

April 29, 2026

FDA signals support for development of psychedelic therapies in mental healthmental health

April 28, 2026

New web series explores path from ophthalmic research to patient access

April 28, 2026

EMA backs plozasiran for rare lipid disorder with high pancreatitis risk

April 27, 2026